A Study of LY3471851 in Participants With Eczema
Public ClinicalTrials.gov record NCT04081350. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Atopic Dermatitis
Study identification
- NCT ID
- NCT04081350
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Nektar Therapeutics
- Industry
- Enrollment
- 48 participants
Conditions and interventions
Conditions
Interventions
- LY3471851 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 3, 2019
- Primary completion
- Jun 23, 2022
- Completion
- Jun 23, 2022
- Last update posted
- Feb 19, 2024
2019 – 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Research Trials, LLC | North Little Rock | Arkansas | 72117 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Center For Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Miami Dermatology and Laser Research | Miami | Florida | 33173 | — |
| ForCare Clinical Research | Tampa | Florida | 33613-1244 | — |
| Medical Dermatology Specialists | Sandy Springs | Georgia | 30328 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| Skin Sciences | Louisville | Kentucky | 40217 | — |
| Derm Center | Troy | Michigan | 48084 | — |
| ActivMed Practices and Research | Portsmouth | New Hampshire | 03801 | — |
| Remington-Davis, Inc | Columbus | Ohio | 43215 | — |
| Unity Clinical Research | Oklahoma City | Oklahoma | 73118 | — |
| Paddington Testing Company Inc | Philadelphia | Pennsylvania | 19103 | — |
| DermDox Centers for Dermatology | Sugarloaf | Pennsylvania | 18249 | — |
| Studies in Dermatology, LLC | Cypress | Texas | 77433 | — |
| Rodgers Dermatology | Frisco | Texas | 75034 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Complete Dermatology | Sugar Land | Texas | 77478 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04081350, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 19, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04081350 live on ClinicalTrials.gov.